Skip to main content

Ryzodeg® 70/30 (insulin degludec and insulin aspart injection)

Ryzodeg® 70/30 (insulin degludec and insulin aspart injection) is a mixture of a long-acting human insulin analog and a rapid-acting human insulin analog, indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus.

Search for Letters

Find documents for this product by entering your search terms in the box below.

 

Text: double click to edit.

Have a Question?

Request information directly from the Novo Nordisk
Medical Information department.